HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PRX302

a modified proaerolysin to produce a prostate-specific antigen-activated protoxin as therapy for prostatic cancer
Networked: 5 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Denmeade, Samuel R: 3 articles (04/2013 - 03/2007)
2. Merchant, Rosemina: 2 articles (04/2013 - 05/2011)
3. Pommerville, Peter: 2 articles (04/2013 - 05/2011)
4. Elhilali, Mostafa M: 1 article (04/2013)
5. Yocum, Richard C: 1 article (04/2013)
6. Roehrborn, Claus G: 1 article (04/2013)
7. Kaplan, Steven A: 1 article (05/2012)
8. Cai, Tommaso: 1 article (06/2011)
9. Malossini, Gianni: 1 article (06/2011)
10. Paolo, Dalla Palma: 1 article (06/2011)

Related Diseases

1. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
2. Prostatic Neoplasms (Prostate Cancer)
3. Pain (Aches)
4. Neoplasms (Cancer)
5. Urinary Bladder Neoplasms (Bladder Cancer)

Related Drugs and Biologics

1. Prostate-Specific Antigen (Semenogelase)
2. proaerolysin

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Injections
3. Aftercare (After-Treatment)